NATCO Pharma Defies Market Pressure with Strong Rally

Shares of

surged up to 6.1% intraday on February 24, 2026, during the first half of trade, outperforming the broader market, which remained under pressure. The stock has now extended its gains for the third consecutive session, reflecting sustained buying interest at lower levels. Trading activity indicated firm investor participation despite overall market weakness. On the technical front, the ₹950–₹961 zone is emerging as a key near-term hurdle for the stock. Market participants are closely monitoring price action around this range to assess the strength of the ongoing move and near-term trend behavior. 📌 Disclaimer: This content is for information only and not investment advice. Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Please consult a SEBI-registered advisor before making any investment decisions.